FDA Adverse Event Malfunction Summary report: N

VITROS ECIQ IMMUNODIAGNOSTIC SYSTEM

MDR report key: 2221799 · Received August 24, 2011

Report

Report Number
1319681-2011-00167
Event Type
Malfunction
Date Received
August 24, 2011
Date of Event
July 28, 2011
Report Date
August 24, 2011
Manufacturer
ORTHO-CLINICAL DIAGNOSTICS
Product Code
KHO
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE INVESTIGATION CONFIRMED THAT HIGHER THAN EXPECTED, VITROS TSH QUALITY CONTROL RESULTS WERE OBTAINED WHILE USING THE VITROS ECIQ SYSTEM. INVESTIGATION CONCLUDED AN INSTRUMENT ISSUE WAS THE MOST LIKELY ASSIGNABLE CAUSE. VITROS TSH PRECISION TESTING WAS PERFORMED WHICH DEMONSTRATED THE VITROS ECIQ SYSTEM WAS NOT PERFORMING OPTIMALLY. AN OCD FIELD ENGINEER PERFORMED SERVICE TO THE REAGENT METERING AND WELL WASH MODULES TO OPTIMIZE THE SYSTEM'S PERFORMANCE. FOLLOWING THESE ACTIONS, THE SYSTEM PERFORMANCE WAS VERIFIED BY PERFORMING A VITROS TSH PRECISION TEST.

Description of Event or Problem · 1

A CUSTOMER OBTAINED A HIGHER THAN EXPECTED, VITROS TSH RESULTS FROM A QUALITY CONTROL SAMPLE WHILE USING THE VITROS ECIQ IMMUNODIAGNOSTIC ANALYZER. HIGHER THAN EXPECTED RESULTS OF 0.132, 0.286, 0.159, 0.179 AND 0.153 MIU/L WERE OBTAINED FROM A LOW LEVEL TSH QUALITY CONTROL FLUID VS. AN EXPECTED MEAN VALUE OF 0.064 MIU/L. NO ERRONEOUS PATIENT SAMPLE RESULTS WERE OBTAINED OR REPORTED FROM THE LABORATORY AS NO PATIENT SAMPLE TESTING WAS PERFORMED WHEN UNACCEPTABLE QUALITY CONTROL RESULTS WERE OBTAINED. HOWEVER, A BIASED PATIENT SAMPLE RESULT OF THE DIRECTION AND MAGNITUDE OBSERVED MAY LEAD TO INAPPROPRIATE PHYSICIAN ACTION IF NOT DETECTED. THERE WAS NO ALLEGATION OF PATIENT HARM. THIS REPORT CORRESPONDS TO ORTHO CLINICAL DIAGNOSTICS INC COMPLAINT NUMBER (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VITROS ECIQ IMMUNODIAGNOSTIC SYSTEM IMMUNODIAGNOSTIC ANALYZER KHO ORTHO-CLINICAL DIAGNOSTICS

Patients

Seq Age Sex Outcome Treatment
1